NPI Lens

Lamont G. Weide, M.D., PH.D., F.A.C.E

NPI 1366410698ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Kansas City, MO

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D., PH.D., F.A.C.E) in Kansas City, Missouri, licensed in MO, with an NPI issued in March 2006. Part D covered 1,541 prescriptions written in 2024, 62% of them generic. Pfizer Inc. reported $14.97 in payments in 2025, mostly food and beverage.

Overview

NPI1366410698
StatusActive
Entity typeIndividual
CredentialM.D., PH.D., F.A.C.E
Sole proprietorNo
NPI issuedMar 11, 2006
Last updated in NPPESNov 8, 2016

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary207RE0101X2002002166MO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (MO)

Part D prescriptions in 2024

Prescriptions (claims)1,541 · 3,389 30-day fills
Patients249
Total drug cost$365,338
Generic share62% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$14.97 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Pfizer Inc.$14.971

What the 2025 payments were for

  • Food and Beverage$14.97 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Kansas City

All 24 endocrinologists in Kansas City · All endocrinologists in Missouri